ポイントオブケア脂質検査の市場規模、シェア、動向分析レポート：製品別、用途別、疾患適応症別、最終用途別、地域別、セグメント予測、2025年～2033年

ポイントオブケア脂質検査市場サマリー

ポイントオブケア脂質検査の世界市場規模は、2024年に7億3,330万米ドルと推計され、2033年には12億6,833万米ドルに達すると予測され、2025年から2033年までのCAGRは6.05%で成長します。市場成長の原動力となっているのは、臨床・非臨床を問わず、特に心血管疾患の早期発見とモニタリングのために、迅速かつ利用しやすい脂質プロファイリングに対する需要の高まりです。

ポイントオブケア脂質検査は、利便性、所要時間の短縮、即時の臨床的意思決定支援を提供し、プライマリ・ケアセンター、薬局、地域医療プログラムでの採用に貢献しています。

脂質異常症や生活習慣病の有病率の増加と心血管リスク管理に対する意識の高まりが、市場の勢いを支えています。これらの検査とデジタルヘルスプラットフォームやモバイル診断の統合は、特に十分なサービスを受けていない地域や農村部での分散型スクリーニングや予防医療の提供をさらに可能にしています。

ポイントオブケア（POC）脂質検査では、ヘルスケアの専門家が、検査機関に検体を送ることなく、患者のいる場所で直接コレステロールや関連脂質レベルを測定することができます。これらの検査は、通常、指を刺して採取する少量の血液サンプルを使用し、携帯機器を通じて迅速に結果を提供します。これにより、特にコレステロールの問題を管理し、心臓病のリスクを軽減するための治療について、医師がより迅速な決定を下すのに役立ちます。

POC脂質検査は、定期検診、慢性疾患管理、救急医療で一般的に使用されています。検査室へのアクセスが限られている遠隔地では特に有用です。技術の継続的な向上により、これらの検査はより小さく、より正確で、より使いやすくなっています。デジタル・ヘルス・システムとの接続性が向上し、検査機能がより高度になったことで、POC脂質検査は予防の重要な一部となりつつあります。

目次

第1章 ポイントオブケア脂質検査市場：調査手法と範囲

第2章 ポイントオブケア脂質検査市場：エグゼクティブサマリー

• 市場スナップショット
• 製品とアプリケーションのスナップショット
• 疾患適応スナップショット
• 最終用途スナップショット
• 競合情勢のスナップショット

第3章 ポイントオブケア脂質検査市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ポーターのファイブフォース分析
• PESTLE分析
• パイプライン分析

第4章 ポイントオブケア脂質検査市場：製品別推定・動向分析

• ポイントオブケア脂質検査市場：製品別変動分析
• 機器
• 消耗品

第5章 ポイントオブケア脂質検査市場：用途別推定・動向分析

• ポイントオブケア脂質検査市場：用途別変動分析
• 高脂血症
• 高トリグリセリド血症
• タンジール病
• 高リポタンパク血症
• 家族性高コレステロール血症
• その他

第6章 ポイントオブケア脂質検査市場：疾患適応症別推定・動向分析

• ポイントオブケア脂質検査市場：疾患適応症別変動分析
• 脂質およびリポタンパク質疾患
• 動脈硬化症
• 肝臓と腎臓の病気
• 糖尿病
• その他

第7章 ポイントオブケア脂質検査市場：最終用途別推定・動向分析

• ポイントオブケア脂質検査市場：最終用途別変動分析
• 病院
• クリニック
• 研究および診断ラボ
• その他

第8章 ポイントオブケア脂質検査市場：地域別ビジネス分析

• 地域別市場のスナップショット
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業分類
• 戦略マッピング
  • 新製品発売
  • パートナーシップ
  • 取得
  • コラボレーション
  • 資金調達
• 主要企業の市場シェア分析（2024年）
• 企業ヒートマップ分析
• 企業プロファイル
  • Callegari Srl
  • Sinocare Inc.
  • Abbott Laboratories
  • MiCoBio
  • Nova Biomedical
  • VivaChek Biotech（Hangzhou）Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • SD Biosensor, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 Global Point of Care Lipid Test Market, By Region, 2021 - 2033 (USD Million)
• Table 4 Global Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
• Table 5 Global Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 6 Global Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 7 Global Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 8 North America Point of Care Lipid Test Market, By Country, 2021 - 2033 (USD Million)
• Table 9 North America Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
• Table 10 North America Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 11 North America Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 12 North America Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 13 U.S. Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 14 U.S. Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 15 U.S Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 16 U.S. Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 17 Canada Point of Care Lipid Test Market, By Application, 2021 - 2033 (USD Million)
• Table 18 Canada Point of Care Lipid Test Market, by Product, 2021 - 2033 (USD Million)
• Table 19 Canada Point of Care Lipid Test Market, by Disease Indication, 2021 - 2033 (USD Million)
• Table 20 Canada Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 21 Mexico Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 22 Mexico Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 23 Mexico Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 24 Mexico Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 25 Europe Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
• Table 26 Europe Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 27 Europe Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 28 Europe Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 29 Europe Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 30 UK Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 31 UK Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 32 UK Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 33 UK Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 34 Germany Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 35 Germany Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 36 Germany Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 37 Germany Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 38 France Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 39 France Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 40 France Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 41 France Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 42 Italy Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 43 Italy Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 44 Italy Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 45 Italy Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 46 Spain Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 47 Spain Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 48 Spain Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 49 Spain Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 50 Sweden Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 51 Sweden Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 52 Sweden Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 53 Sweden Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 54 Norway Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 55 Norway Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 56 Norway Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 57 Norway Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 58 Denmark Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 59 Denmark Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 60 Denmark Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 61 Denmark Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 62 Asia Pacific Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
• Table 63 Asia Pacific Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 64 Asia Pacific Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 65 Asia Pacific Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 66 Asia Pacific Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 67 Japan Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 68 Japan Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 69 Japan Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 70 Japan Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 71 China Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 72 China Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 73 China Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 74 China Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 75 India Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 76 India Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 77 India Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 78 India Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 79 Australia Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 80 Australia Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 81 Australia Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 82 Australia Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 83 Thailand Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 84 Thailand Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 85 Thailand Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 86 Thailand Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 87 South Korea Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 88 South Korea Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 89 South Korea Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 90 South Korea Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 91 Latin America Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
• Table 92 Latin America Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 93 Latin America Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 94 Latin America Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 95 Latin America Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 96 Brazil Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 97 Brazil Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 98 Brazil Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 99 Brazil Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 100 Argentina Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 101 Argentina Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 102 Argentina Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 103 Argentina Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 104 MEA Point of Care Lipid Test Market, by country, 2021 - 2033 (USD Million)
• Table 105 MEA Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 106 MEA Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 107 MEA Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 108 MEA Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 109 South Africa Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 110 South Africa Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 111 South Africa Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 112 South Africa Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 113 Saudi Arabia Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 114 Saudi Arabia Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 115 Saudi Arabia Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 116 Saudi Arabia Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 117 UAE Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD Million)
• Table 118 UAE Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 119 UAE Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 120 UAE Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)
• Table 121 Kuwait Point of Care Lipid Test Market, by Application, 2021 - 2033 (USD)
• Table 122 Kuwait Point of Care Lipid Test Market, By Product, 2021 - 2033 (USD Million)
• Table 123 Kuwait Point of Care Lipid Test Market, By Disease Indication, 2021 - 2033 (USD Million)
• Table 124 Kuwait Point of Care Lipid Test Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Market summary
• Fig. 4 Market segmentation & scope
• Fig. 5 Market size and growth prospects
• Fig. 6 Global Point of Care Lipid Test market- Key market driver analysis
• Fig. 7 Global Point of Care Lipid Test market - Key market restraint analysis
• Fig. 8 Penetration & growth prospect mapping
• Fig. 9 Global Point of Care Lipid Test market - Porter's analysis
• Fig. 10 Global Point of Care Lipid Test market - PESTEL analysis
• Fig. 11 Global Point of Care Lipid Test market product outlook key takeaways
• Fig. 12 Global Point of Care Lipid Test market: Product movement analysis
• Fig. 13 Instruments market estimates, 2021 - 2033 (USD Million)
• Fig. 14 Consumables market estimates, 2021 - 2033 (USD Million)
• Fig. 15 Global Point of Care Lipid Test market Application outlook key takeaways
• Fig. 16 Global Point of Care Lipid Test market: Application movement analysis
• Fig. 17 Hyperlipidemia market estimates, 2021 - 2033 (USD Million)
• Fig. 18 Hypertriglyceridemia market estimates, 2021 - 2033 (USD Million)
• Fig. 19 Tangier Disease market estimates, 2021 - 2033 (USD Million)
• Fig. 20 Hyperlipoproteinemia market estimates, 2021 - 2033 (USD Million)
• Fig. 21 Familial Hypercholesterolemia market estimates, 2021 - 2033 (USD Million)
• Fig. 22 Global Point of Care Lipid Test market Disease Indication outlook key takeaways
• Fig. 23 Global Point of Care Lipid Test market: Disease Indication movement analysis
• Fig. 24 Lipid and Lipoprotein Disorders market estimates, 2021 - 2033 (USD Million)
• Fig. 25 Atherosclerosis market estimates, 2021 - 2033 (USD Million)
• Fig. 26 Liver and Renal Diseases market estimates, 2021 - 2033 (USD Million)
• Fig. 27 Diabetes Mellitus market estimates, 2021 - 2033 (USD Million)
• Fig. 28 Global Point of Care Lipid Test market End Use outlook key takeaways
• Fig. 29 Global Point of Care Lipid Test market: End Use movement analysis
• Fig. 30 Hospitals market estimates, 2021 - 2033 (USD Million)
• Fig. 31 Clinics market estimates, 2021 - 2033 (USD Million)
• Fig. 32 Research and Diagnostic Laboratories market estimates, 2021 - 2033 (USD Million)
• Fig. 33 Regional marketplace: Key takeaways
• Fig. 34 Global Point of Care Lipid Test market: Regional movement analysis
• Fig. 35 North America Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 36 U.S. Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 37 Canada Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 38 Mexico Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 39 Europe Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 40 UK Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 41 Germany Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 42 France Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 43 Spain Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 44 Italy Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 45 Denmark Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 46 Sweden Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 47 Norway Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 48 Asia Pacific Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 49 Japan Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 50 China Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 51 India Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 52 South Korea Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 53 Australia Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 54 Thailand Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 55 Latin America Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 56 Brazil Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 57 Argentina Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 58 MEA Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 59 South Africa Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 60 Saudi Arabia Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 61 UAE Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 62 Kuwait Point of Care Lipid Test market, 2021 - 2033 (USD Million)
• Fig. 63 Strategy framework

Point of Care Lipid Test Market Summary

The global point of care lipid test market size was estimated at USD 733.3 million in 2024 and is projected to reach USD 1,268.33 million by 2033, growing at a CAGR of 6.05% from 2025 to 2033. Market growth is driven by rising demand for rapid and accessible lipid profiling in both clinical and non-clinical settings, especially for early detection and monitoring of cardiovascular conditions.

Point of care lipid testing offers convenience, reduced turnaround time, and immediate clinical decision-making support, contributing to its adoption across primary care centers, pharmacies, and community health programs.

The increasing prevalence of dyslipidemia and lifestyle-related disorders, combined with growing awareness of cardiovascular risk management, supports the market's momentum. Integration of these tests with digital health platforms and mobile diagnostics is further enabling decentralized screening and preventive care delivery, particularly in underserved and rural regions.

Point of care (POC) lipid testing allows healthcare professionals to measure cholesterol and related lipid levels directly at the patient's location, without sending samples to a lab. These tests use small blood samples, usually taken from a finger prick, and provide quick results through portable devices. This helps doctors make faster decisions about treatment, especially for managing cholesterol problems and reducing heart disease risk.

POC lipid tests are commonly used in regular check-ups, chronic disease management, and emergency care. They are especially helpful in remote areas where lab access is limited. Ongoing improvements in technology are making these tests smaller, more accurate, and easier to use. With better connectivity to digital health systems and more advanced testing features, POC lipid testing is becoming an important part of preventive.

Global Point of Care Lipid Test Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global point of care lipid test market report based on product, application, disease indication, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Hyperlipidemia
• Hypertriglyceridemia
• Tangier Disease
• Hyperlipoproteinemia
• Familial Hypercholesterolemia
• Others
• Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Lipid and Lipoprotein Disorders
• Atherosclerosis
• Liver and Renal Diseases
• Diabetes Mellitus
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics
• Research and Diagnostic Laboratories
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Point of Care Lipid Test Market: Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Application Segment
    • 1.1.1.3. Disease Indication segment
    • 1.1.1.4. End Use
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
  • 1.4.3. Objective - 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Point of Care Lipid Test Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Product and Application Snapshot
• 2.3. Disease Indication Snapshot
• 2.4. End Use Snapshot
• 2.5. Competitive Landscape Snapshot

Chapter 3. Point of Care Lipid Test Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Porter's Five Forces Analysis
• 3.5. PESTLE Analysis
• 3.6. Pipeline Analysis

Chapter 4. Point of Care Lipid Test Market: Product Estimates & Trend Analysis

• 4.1. Point of Care Lipid Test Market: Product Movement Analysis
• 4.2. Instruments
  • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.3. Consumables
  • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Point of Care Lipid Test Market: Application Estimates & Trend Analysis

• 5.1. Point of Care Lipid Test Market: Application Movement Analysis
• 5.2. Hyperlipidemia
  • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.3. Hypertriglyceridemia
  • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Tangier Disease
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Hyperlipoproteinemia
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Familial Hypercholesterolemia
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Point of Care Lipid Test Market: Indication Outlook Estimates & Trend Analysis

• 6.1. Point of Care Lipid Test Market: Technology Movement Analysis
• 6.2. Lipid and Lipoprotein Disorders
  • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.3. Atherosclerosis
  • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Liver and Renal Diseases
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diabetes Mellitus
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Point of Care Lipid Test Market: End Use Estimates & Trend Analysis

• 7.1. Point of Care Lipid Test Market: End Use Movement Analysis
• 7.2. Hospitals
  • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.3. Clinics
  • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Research and Diagnostic Laboratories
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Others
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Point of Care Lipid Test Market: Regional Business Analysis

• 8.1. Regional Market Snapshot
• 8.2. North America
  • 8.2.1. North America Point of Care Lipid Test Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.2.2.2. Key Country Dynamics
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. Reimbursement Scenario
    • 8.2.2.5. Competitive Scenario
  • 8.2.3. Canada
    • 8.2.3.1. Canada Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.2.3.2. Key Country Dynamics
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Reimbursement Scenario
    • 8.2.3.5. Competitive Scenario
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.2.4.2. Key Country Dynamics
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. Reimbursement Scenario
    • 8.2.4.5. Competitive Scenario
• 8.3. Europe
  • 8.3.1. Europe Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. UK Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.2.2. Key Country Dynamics
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. Competitive Scenario
  • 8.3.3. Germany
    • 8.3.3.1. Germany Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.3.2. Key Country Dynamics
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Competitive Scenario
  • 8.3.4. Spain
    • 8.3.4.1. Spain Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.4.2. Key Country Dynamics
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Competitive Scenario
  • 8.3.5. France
    • 8.3.5.1. France Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.5.2. Key Country Dynamics
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Reimbursement Scenario
    • 8.3.5.5. Competitive Scenario
  • 8.3.6. Italy
    • 8.3.6.1. Italy Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.6.2. Key Country Dynamics
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Reimbursement Scenario
    • 8.3.6.5. Competitive Scenario
  • 8.3.7. Denmark
    • 8.3.7.1. Denmark Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.7.2. Key Country Dynamics
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Reimbursement Scenario
    • 8.3.7.5. Competitive Scenario
  • 8.3.8. Sweden
    • 8.3.8.1. Sweden Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.8.2. Key Country Dynamics
    • 8.3.8.3. Regulatory Framework
    • 8.3.8.4. Reimbursement Scenario
    • 8.3.8.5. Competitive Scenario
  • 8.3.9. Norway
    • 8.3.9.1. Norway Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.3.9.2. Key Country Dynamics
    • 8.3.9.3. Regulatory Framework
    • 8.3.9.4. Reimbursement Scenario
    • 8.3.9.5. Competitive Scenario
• 8.4. Asia Pacific
  • 8.4.1. Asia-Pacific Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Japan Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.2.2. Key Country Dynamics
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. Competitive Scenario
  • 8.4.3. China
    • 8.4.3.1. China Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.3.2. Key Country Dynamics
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Competitive Scenario
  • 8.4.4. India
    • 8.4.4.1. India Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.4.2. Key Country Dynamics
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. Competitive Scenario
  • 8.4.5. South Korea
    • 8.4.5.1. South Korea Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.5.2. Key Country Dynamics
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Competitive Scenario
  • 8.4.6. Thailand
    • 8.4.6.1. Thailand Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.6.2. Key Country Dynamics
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Competitive Scenario
  • 8.4.7. Australia
    • 8.4.7.1. Australia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.4.7.2. Key Country Dynamics
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Competitive Scenario
• 8.5. Latin America
  • 8.5.1. Latin America Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.5.2.2. Key Country Dynamics
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Competitive Scenario
  • 8.5.3. Argentina
    • 8.5.3.1. Argentina Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.5.3.2. Key Country Dynamics
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. Competitive Scenario
• 8.6. MEA
  • 8.6.1. MEA Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. South Africa Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.6.2.2. Key Country Dynamics
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Competitive Scenario
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Saudi Arabia Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.6.3.2. Key Country Dynamics
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Competitive Scenario
  • 8.6.4. UAE
    • 8.6.4.1. UAE Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.6.4.2. Key Country Dynamics
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement Scenario
    • 8.6.4.5. Competitive Scenario
  • 8.6.5. Kuwait
    • 8.6.5.1. Kuwait Point of Care Lipid Test Market, 2021 - 2033 (USD Million)
    • 8.6.5.2. Key Country Dynamics
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement Scenario
    • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
  • 9.2.1. New Product Launch
  • 9.2.2. Partnerships
  • 9.2.3. Acquisition
  • 9.2.4. Collaboration
  • 9.2.5. Funding
• 9.3. Key Company Market Share Analysis, 2024
• 9.4. Company Heat Map Analysis
• 9.5. Company Profiles
  • 9.5.1. Callegari Srl
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. Sinocare Inc.
    • 9.5.2.1. Company Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Abbott Laboratories
    • 9.5.3.1. Company Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. MiCoBio
    • 9.5.4.1. Company Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. Nova Biomedical
    • 9.5.5.1. Company Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. VivaChek Biotech (Hangzhou) Co., Ltd.
    • 9.5.6.1. Company Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. F. Hoffmann-La Roche Ltd.
    • 9.5.7.1. Company Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. Menarini Group
    • 9.5.8.1. Company Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. SD Biosensor, Inc.
    • 9.5.9.1. Company Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives